title: Combination of imatinib and cytarabine for the treatment of Philadelphia chromosome positive acute lymphoblastic leukemia.
authors.forename: Daniel
authors.initials: D
authors.lastname: Morgensztern
authors.forename: Manuel F
authors.initials: MF
authors.lastname: Rosado
authors.forename: Luis E
authors.initials: LE
authors.lastname: Raez
authors.forename: Edgardo S
authors.initials: ES
authors.lastname: Santos
authors.forename: Peter A
authors.initials: PA
authors.lastname: Cassileth
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D001549:Benzamides; D003561:Cytarabine / Q000008:administration & dosage*; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D008875:Middle Aged; D010879:Piperazines / Q000008:administration & dosage*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis / Q000188:drug therapy*; D011743:Pyrimidines / Q000008:administration & dosage*; D012074:Remission Induction / Q000379:methods
chemical_list: D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D003561:Cytarabine; D000068877:Imatinib Mesylate